These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 10021861)

  • 61. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 62. Von Willebrand disease and angiodysplasia responding to atorvastatin.
    Sohal M; Laffan M
    Br J Haematol; 2008 Jun; 142(2):308-9. PubMed ID: 18510690
    [No Abstract]   [Full Text] [Related]  

  • 63. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency.
    Hegele RA; Little JA; Connelly PW
    Atherosclerosis; 1999 Mar; 143(1):219-22. PubMed ID: 10208500
    [No Abstract]   [Full Text] [Related]  

  • 64. Routine statin treatment after acute coronary syndromes?
    Acevedo M; Sprecher DL; Lauer MS; Francis G
    Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242
    [No Abstract]   [Full Text] [Related]  

  • 65. Statin loading for acute coronary syndromes.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    Curr Opin Cardiol; 2010 Jul; 25(4):373-8. PubMed ID: 20520540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of statin therapy on circulating conjugated dienes, a measure of LDL oxidation.
    Vasankari T; Ahotupa M; Viikari J; Nuotio I; Vuorenmaa T; Strandberg T; Vanhanen H; Tikkanen MJ
    Atherosclerosis; 2005 Mar; 179(1):207-9. PubMed ID: 15721029
    [No Abstract]   [Full Text] [Related]  

  • 67. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.
    Meena AK; Ratnam DV; Chandraiah G; Ankola DD; Rao PR; Kumar MN
    Lipids; 2008 Mar; 43(3):231-41. PubMed ID: 18196308
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
    Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
    [No Abstract]   [Full Text] [Related]  

  • 69. More on switching statins: comments from Pfizer.
    Lloyd K
    BMJ; 2006 Sep; 333(7569):655; author reply 655-6. PubMed ID: 16990337
    [No Abstract]   [Full Text] [Related]  

  • 70. Alternate-day statin therapy for the treatment of hyperlipidemia.
    Reindl EK; Wright BM; Wargo KA
    Ann Pharmacother; 2010 Sep; 44(9):1459-70. PubMed ID: 20702760
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Statin is a two-edged sword in liver enzyme.
    Li N; Yang YJ
    Int J Cardiol; 2014 Feb; 171(2):e18. PubMed ID: 24360161
    [No Abstract]   [Full Text] [Related]  

  • 72. Safety of statin therapy in patients with mitochondrial diseases.
    Hannah-Shmouni F; Al-Sarraf A; Frohlich J; Mezei MM; Sirrs S; Mattman A
    J Clin Lipidol; 2013; 7(2):182. PubMed ID: 23415441
    [No Abstract]   [Full Text] [Related]  

  • 73. What price atorvastatin?
    Drug Ther Bull; 2012 Jul; 50(7):73. PubMed ID: 22764068
    [No Abstract]   [Full Text] [Related]  

  • 74. HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study.
    Mackie FE; Rosenberg AR; Harmer JA; Kainer G; Celermajer DS
    Acta Paediatr; 2010 Mar; 99(3):457-9. PubMed ID: 20050832
    [No Abstract]   [Full Text] [Related]  

  • 75. Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
    Nordmann A; Schwartz G; Vale N; Bucher HC; Briel M
    Heart; 2016 May; 102(9):653-4. PubMed ID: 26908101
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical implications of new drugs for lowering plasma cholesterol concentrations.
    Illingworth DR
    Drugs; 1991 Feb; 41(2):151-60. PubMed ID: 1709846
    [No Abstract]   [Full Text] [Related]  

  • 77. Not a graves' situation.
    Ruchala M; Szczepanek E; Puszczewicz M; Sosnowski P; Sowinski J
    Am J Med; 2011 Mar; 124(3):210-4. PubMed ID: 21396501
    [No Abstract]   [Full Text] [Related]  

  • 78. [Comparative study of lipid lowering effect and influence on platelet aggregation of atorvastatin and simvastatin in patients ischemic heart disease with type II diabetes and combined hyperlipidemia].
    Vasiutina EI; Metel'kaya VA; Akhmedzhanov NM; Raszzivin VA; Oganov RG
    Kardiologiia; 2003; 43(1):30-5. PubMed ID: 12913995
    [No Abstract]   [Full Text] [Related]  

  • 79. Statin treatment in patients with elevated liver enzymes: pitch to proceed.
    Berkelhammer C; Lerma EV
    J Clin Lipidol; 2012; 6(4):310-1. PubMed ID: 22836066
    [No Abstract]   [Full Text] [Related]  

  • 80. Reducing residual risk in secondary prevention of cardiovascular disease.
    Stone NJ
    Circulation; 2012 Apr; 125(16):1958-60. PubMed ID: 22461417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.